Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Zürcher Kantonalbank: UDG Health

7th Jul 2021 13:05

Zürcher Kantonalbank (IRSH) Form 8.3 - Zürcher Kantonalbank: UDG Health 07-Jul-2021 / 14:05 CET/CEST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

6Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

KEY INFORMATION

 

Name of person dealing (Note 1)

Zürcher Kantonalbank

Company dealt in

UDG Health

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares

Date of dealing

6.7.2021

 

INTERESTS AND SHORT POSITIONS

 

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

1.19

(%)

Number

 

(%)

(1) Relevant securities

3'011'024

 

 

(2) Derivatives (other than options)

 

 

(3) Options and agreements to purchase/sell

 

 

Total

3'011'024

 

 

 

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

Ap20

 

 

DEALINGS (Note 4)

 

Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (Note 5)

 

 

 

 

 

Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

 

 

Options transactions in respect of existing relevant securities

 

 

Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Title transfer collateral arrangement

 

+3'728

 n/a

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  /NO

 

Date of disclosure

07.07.2021

Contact name

Matthias Nänni

Telephone number

+41442923278

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection (Note 10)

 

 

Category Code:RET - UDG Health
TIDM:IRSH
LEI Code:165GRDQ39W63PHVONY02
Sequence No.:115897
EQS News ID:1216234
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Related Shares:

UDG.L
FTSE 100 Latest
Value8,809.74
Change53.53